Results
1870
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
1870 companies
GI Innovation
Market Cap: ₩1.2t
A bio-venture company, engages in the research and development of protein new drugs.
A358570
₩18,260.00
7D
-2.4%
1Y
59.3%
Vita Life Sciences
Market Cap: AU$136.3m
A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.
VLS
AU$2.44
7D
-4.7%
1Y
13.0%
EirGenix
Market Cap: NT$19.0b
Operates as a contract development and manufacturing company in Taiwan and internationally.
6589
NT$62.90
7D
3.5%
1Y
-27.0%
Mercury Laboratories
Market Cap: ₹1.0b
Engages in manufacturing, selling, exporting, and dealing in various pharmaceutical drugs and medicines for mother and child healthcare in India and internationally.
538964
₹845.40
7D
0.5%
1Y
-15.9%
Parataxis Korea
Market Cap: ₩161.8b
A clinical stage biotech company, engages in the development of therapeutics for the treatment of ulcerative colitis, fibrotic diseases, and cancers worldwide.
A288330
₩1,847.00
7D
-6.5%
1Y
-54.0%
Tuoxin Pharmaceutical GroupLtd
Market Cap: CN¥3.9b
Engages in the research and development, production and sales of nucleoside (acid) APIs and pharmaceutical intermediates in China.
301089
CN¥30.70
7D
-3.5%
1Y
7.7%
Bonraybio
Market Cap: NT$4.2b
A development stage company, manufactures medical instruments and solutions for the male infertility market.
6955
NT$167.50
7D
-0.9%
1Y
45.9%
Orient Pharma
Market Cap: NT$5.7b
Engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.
4166
NT$25.40
7D
-2.3%
1Y
-1.6%
HARBIN GLORIA PHARMACEUTICALS
Market Cap: CN¥7.1b
Harbin Gloria Pharmaceuticals Co., Ltd engages in the research, development, production, and sale of pharmaceutical products primarily in the People’s Republic of China.
002437
CN¥3.16
7D
-7.9%
1Y
58.0%
CARsgen Therapeutics Holdings
Market Cap: HK$10.7b
An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.
2171
HK$19.36
7D
-6.7%
1Y
427.5%
MOA Life Plus
Market Cap: ₩59.9b
Engages in the medicine and consumer business in South Korea.
A142760
₩1,535.00
7D
-2.1%
1Y
-8.7%
LanZhou Foci PharmaceuticalLtd
Market Cap: CN¥4.4b
Research and development, production, and sales of traditional chinese medicines and health products in China.
002644
CN¥8.66
7D
-2.5%
1Y
21.1%
Hunan Hansen Pharmaceutical
Market Cap: CN¥3.2b
Produces and sells traditional Chinese preparations in China and internationally.
002412
CN¥6.33
7D
-3.1%
1Y
15.9%
D&D Pharmatech
Market Cap: ₩2.0t
A clinical-stage biotech company, develops medicines in South Korea and the United States.
A347850
₩186,800.00
7D
13.1%
1Y
334.4%
Vitrafy Life Sciences
Market Cap: AU$79.8m
Engages in the research, development, and commercialization of cryopreservation solutions in Australia.
VFY
AU$1.25
7D
7.8%
1Y
n/a
Tasly Pharmaceutical Group
Market Cap: CN¥23.8b
Engages in the pharmaceutical business in China and internationally.
600535
CN¥15.95
7D
1.4%
1Y
10.7%
Advagene Biopharma
Market Cap: NT$2.1b
Engages in the research and development of vaccine technology and related products in Taiwan.
6709
NT$35.25
7D
15.6%
1Y
44.5%
Zhejiang Haisen Pharmaceutical
Market Cap: CN¥3.5b
Engages in the research and development, production, and sale of chemical active pharmaceutical ingredient and intermediates in China.
001367
CN¥23.51
7D
-3.3%
1Y
34.7%
Beijing Foyou PharmaLTD
Market Cap: CN¥10.6b
Engages in the research and development, production, and sale of pharmaceutical preparations and medical equipment.
601089
CN¥22.75
7D
-3.6%
1Y
48.9%
Indegene
Market Cap: ₹137.3b
Operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally.
INDGN
₹571.90
7D
-2.4%
1Y
-13.8%
Panchsheel Organics
Market Cap: ₹1.8b
Engages in the manufacture and trading of bulk drugs and intermediates in India and internationally.
531726
₹138.60
7D
-3.0%
1Y
-40.9%
NGL Fine-Chem
Market Cap: ₹8.9b
Manufactures and sells pharmaceuticals and intermediates for usage in veterinary and human health in India, Europe, the Asia Pacific, the United States, and internationally.
524774
₹1,435.40
7D
5.4%
1Y
-31.8%
Holy Stone Healthcare
Market Cap: NT$1.5b
Develops and sells hyaluronic acid related therapeutic products.
4194
NT$10.50
7D
2.4%
1Y
-40.0%
Jagsonpal Pharmaceuticals
Market Cap: ₹15.7b
Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.
JAGSNPHARM
₹234.91
7D
-3.5%
1Y
41.5%
Anya Biopharm
Market Cap: NT$2.3b
A pharmaceutical company, develops platform for oral peptides.
7776
NT$46.95
7D
-12.2%
1Y
n/a
OncoSil Medical
Market Cap: AU$31.1m
A medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma.
OSL
AU$1.65
7D
-13.2%
1Y
-68.3%
Boji Medical TechnologyLtd
Market Cap: CN¥3.9b
Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.
300404
CN¥10.08
7D
-4.4%
1Y
31.8%
Sinotherapeutics
Market Cap: CN¥4.8b
A specialty pharmaceutical company, develops generic and formulation products in China.
688247
CN¥10.75
7D
-1.7%
1Y
32.1%
PhytoHealth
Market Cap: NT$3.1b
Researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and dietary supplements in Taiwan.
4108
NT$15.70
7D
-2.8%
1Y
-12.3%
Jinghua Pharmaceutical Group
Market Cap: CN¥6.0b
Engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China.
002349
CN¥7.19
7D
-2.8%
1Y
0%
IMB Dx
Market Cap: ₩143.7b
Provides liquid biopsy platform in South Korea.
A461030
₩10,250.00
7D
-6.0%
1Y
-43.9%
Savior Lifetec
Market Cap: NT$5.7b
A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.
4167
NT$17.90
7D
-0.8%
1Y
-16.0%
Eusol BiotechLtd
Market Cap: NT$1.0b
Focuses on research and development of new biotech drugs for sleep disorders.
6652
NT$7.64
7D
-4.4%
1Y
-4.5%
Zhejiang Medicine
Market Cap: CN¥13.8b
Manufactures and sells life nutrition and pharmaceutical products in China.
600216
CN¥14.35
7D
-2.6%
1Y
-6.6%
AFT Pharmaceuticals
Market Cap: NZ$293.6m
Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$2.80
7D
7.3%
1Y
-12.5%
Medico Remedies
Market Cap: ₹4.0b
Develops, manufactures, and sells pharmaceutical and nutraceutical products in India.
540937
₹48.84
7D
25.9%
1Y
-2.2%